Characterisation of the NRF2 transcriptional network and its response to chemical insult in primary human hepatocytes: implications for prediction of drug-induced liver injury

The transcription factor NRF2, governed by its repressor KEAP1, protects cells against oxidative stress. There is interest in modelling the NRF2 response to improve the prediction of clinical toxicities such as drug-induced liver injury (DILI). However, very little is known about the makeup of the NRF2 transcriptional network and its response to chemical perturbation in primary human hepatocytes (PHH), which are often used as a translational model for investigating DILI. Here, microarray analysis identified 108 transcripts (including several putative novel NRF2-regulated genes) that were both downregulated by siRNA targeting NRF2 and upregulated by siRNA targeting KEAP1 in PHH. Applying weighted gene co-expression network analysis (WGCNA) to transcriptomic data from the Open TG-GATES toxicogenomics repository (representing PHH exposed to 158 compounds) revealed four co-expressed gene sets or 'modules' enriched for these and other NRF2-associated genes. By classifying the 158 TG-GATES compounds based on published evidence, and employing the four modules as network perturbation metrics, we found that the activation of NRF2 is a very good indicator of the intrinsic biochemical reactivity of a compound (i.e. its propensity to cause direct chemical stress), with relatively high sensitivity, specificity, accuracy and positive/negative predictive values. We also found that NRF2 activation has lower sensitivity for the prediction of clinical DILI risk, although relatively high specificity and positive predictive values indicate that false positive detection rates are likely to be low in this setting. Underpinned by our comprehensive analysis, activation of the NRF2 network is one of several mechanism-based components that can be incorporated into holistic systems toxicology models to improve mechanistic understanding and preclinical prediction of DILI in man.Medicinal Chemistr

Insulin-like growth factor and growth hormone receptor in postpartum lactating beef cows Fator de crescimento semelhante à insulina e receptor do hormônio do crescimento no pós-parto de vacas de corte

The objective of this study was to evaluate the plasma concentrations of insulin-like growth factor-I (IGF-I), and the mRNA hepatic expression of IGF-I and of the growth hormone receptors GHR and GHR 1A, in postpartum beef cows. Four Angus and four crossbred (Angus x Nelore) postpartum suckled beef cows were used. Liver and blood samples were collected every 10 days, from calving to 40 days postpartum, for gene expression and for &#946;-hydroxybutyrate and IGF-I assays, respectively. Samples for progesterone assay were collected every other day, from day 10 to 40 postpartum. Three cows ovulated before 40 days postpartum. IGF-I concentration was higher in Angus x Nelore than in Angus cows. There was no difference in the expression of GHR, GHR 1A and IGF-I according to breed or ovulatory status. IGF-I concentrations were higher in crossbred cows, but have not changed according to postpartum ovulatory status. Moreover, changes in postpartum IGF-I concentrations are not associated with changes in liver GHR, GHR 1A and IGF-I mRNA expression in either breed.<br>O objetivo deste estudo foi avaliar as concentrações plasmáticas do fator de crescimento semelhante à insulina tipo I (IGF-I) e a expressão hepática de mRNA de IGF-I e dos receptores do hormônio de crescimento GHR e GHR 1A, no pós-parto de vacas de corte. Quatro vacas Angus e quatro mestiças (Angus x Nelore) lactantes foram usadas durante o período de pós-parto. As coletas de tecido hepático e de sangue foram realizadas a cada dez dias, do parto até 40 dias pós-parto, para a avaliação da expressão gênica, e análise de &#946;-hidroxibutirato e IGF-I, respectivamente. As amostras para análise de progesterona foram coletadas a cada dois dias, dos dez aos 40 dias pós-parto. Três vacas ovularam antes dos 40 dias pós-parto. A concentração de IGF-I foi maior em vacas Angus x Nelore do que em vacas Angus. Não houve diferença na expressão hepática de GHR, GHR 1A e IGF-I de acordo com a raça ou com a ovulação. As concentrações de IGF-I foram maiores em vacas cruzadas, e não mudaram com o status ovulatório pós-parto. Além disso, as mudanças observadas na concentração de IGF-I, durante o período pós-parto, não estão associadas a alterações na expressão hepática de mRNA de GHR, GHR 1A e IGF-I, em nenhuma das duas raças